Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)
Clinical trial NCT00473928 · COMPLETED
Trial details
- NCT number
- NCT00473928
- Sponsor
- Potentia Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2010-02-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.